Skip to main content
Log in

High levels of CA125 (over 1,000 IU/ml) in patients with gynecologic disease and no malignant conditions: three cases and literature review

  • Case Report
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Objective

To report the very high serum levels of CA125 in patients with benign gynecologic disease which manifests as pelvic mass.

Methods

Clinical data of three cases with high levels of CA125 over 1,000 IU/ml and benign gynecologic conditions were gathered. in Vali-Asr hospital.

Results

Three patients were scheduled for laparatomy as ovarian cancer and leiomyosarcoma. Histologic results after laparatomy showed uterine myoma in two patients and endometrioma in a third patient.

Conclusion

High levels of CA125 over 1,000 IU/ml, may be showed in other gynecologic conditions with no malignancy. So, other clinical and imaging data could be helpful for differential diagnosis of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bast RC Jr, Badgwell D, LuZ, Marquez R et al (2005) New tumor markers: CA125 and beyond Int J Gynecol Cancer 15(3):274–281

    Article  PubMed  Google Scholar 

  2. Diamandis EP, Scorials A, Facchioli S et al (2003) Human kallikrein 6 (hK6): A new potential biomarker for diagnosis and prognosis of ovarian carcinoma. J Clin Oncol 21:1035–1043

    Article  PubMed  CAS  Google Scholar 

  3. Li HJ, Shen K, Lang JH, Wu M, Hung HF et al (2003) Benign ovarian tumor with ascitis and high serum levels of CA125: report of 3 casess. Zhanghua FU Chun Ke Za Zhi 38(3):147–149

    Google Scholar 

  4. Shian CS, Chang MY, Chiang CH, Hsieh CC, Hsich TT (2003) Ovarian endometrioma associated with very high serum CA125 levels. Chang Gung Med J 26(9):695–699

    Google Scholar 

  5. Phupong V, Chen O, Ultchaswadi P (2004) High level of CA125 due to large endometrioma. J Med Assoc Thai 87(9):1108–1111

    PubMed  Google Scholar 

  6. Nikolic B, Mitrovic A, Lazic J (2006) Mean of CA125 in making therapy decisison in adnexal inflammatory tumors. Bosn J Basic Med SCI 6(2):3–96

    PubMed  Google Scholar 

  7. Chamande SA, Eleonu B, Hamid AM (1996) High levels of CA125 in a case of a parasitic leiomyoma presenting as an abdominal mass. Gynecologic Oncology 61(2):297–298

    Article  Google Scholar 

  8. Vieira SC, Pimental LH, Ribrro JC, de Andrade Note AF, de Santana Jo (2003) Meigs syndrome with elevated CA125:case report. Sao Paulo Med J 121(5):21–22

    Article  Google Scholar 

  9. Dawood MY, Khan Dawood FS (1994) Plasma insulin like growth factor-I, Ca125, estrogen, progesterone in women with leiomyomas. Fertil Stril 61:617–621

    CAS  Google Scholar 

  10. vander Spuy ZM, Wood M, Freggen G, Salie Hendricks M (1993) Serum CA125 concentration in women with endometriosis or uterine fibroids treated with GNRH-agonists analogues. S Afr Med J 83:510–513

    CAS  Google Scholar 

  11. Mehmet Yilmazer, Murat Sonmezer, Mete Gungor, Veysel Fenkci, Serhan Cevrioglu (2003) Unusually elevated serum carbohydrate antigen 125 (Ca125) and CA19-9 levels as a result of unruptured bilateral endometrioma. Aust NZ J Obstet Gynaecol 43(4):329

    Article  Google Scholar 

  12. Johansson J, Santala M, Kauppila A (1998) Explosive rise of serum CA125 following the rupture of ovarian endometrioma. Hum Reprod 13:3503–3504

    Article  PubMed  CAS  Google Scholar 

  13. Kashyap RJ (1999) Extremely elevated serum CA125 due to endometriosis. Aust NZ J Obstet Gynaeco l39:269–270

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mojgan Karimi Zarchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghaemmaghami, F., Karimi Zarchi, M. & Hamedi, B. High levels of CA125 (over 1,000 IU/ml) in patients with gynecologic disease and no malignant conditions: three cases and literature review. Arch Gynecol Obstet 276, 559–561 (2007). https://doi.org/10.1007/s00404-007-0381-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-007-0381-x

Keywords

Navigation